Tolerance of the cell infusions: adverse clinical events
| Clinical event . | CD8+ cells . | CD4+plus CD8+ cells . |
|---|---|---|
| Chills | 15 | 1 |
| Fever | 10 | 2 |
| Headache | 6 | 0 |
| Nausea | 5 | 0 |
| Rigors | 4 | 1 |
| Bronchospasm | 3 | 2 |
| Myalgias | 4 | 0 |
| Pruritus | 0 | 2 |
| Rash | 0 | 2 |
| Blurred vision | 1 | 0 |
| Hypertension | 0 | 1 |
| Total episodes | 48 | 11 |
| Total episodes/total infusions (%) | 48/161 (30) | 11/51 (22) |
| Clinical event . | CD8+ cells . | CD4+plus CD8+ cells . |
|---|---|---|
| Chills | 15 | 1 |
| Fever | 10 | 2 |
| Headache | 6 | 0 |
| Nausea | 5 | 0 |
| Rigors | 4 | 1 |
| Bronchospasm | 3 | 2 |
| Myalgias | 4 | 0 |
| Pruritus | 0 | 2 |
| Rash | 0 | 2 |
| Blurred vision | 1 | 0 |
| Hypertension | 0 | 1 |
| Total episodes | 48 | 11 |
| Total episodes/total infusions (%) | 48/161 (30) | 11/51 (22) |
Values are number of episodes unless otherwise indicated.